Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s State FDA To Implement Electronic Tracking Network To Improve Drug Safety

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State SFDA will implement an electronic ID-based drug-tracking system this year, the drug watchdog announced at a monthly press conference April 8
Advertisement

Related Content

China Beefs Up Quality Control System With New GMP Regulations: Shanghai FDA Leaders At PharmAsia Summit
China Beefs Up Quality Control System With New GMP Regulations: Shanghai FDA Leaders At PharmAsia Summit
China Launches New Drug Code System To Step Up Drug Safety Monitoring
China Launches New Drug Code System To Step Up Drug Safety Monitoring
China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
China To Step Up Supervision Of APIs And Drug Excipients – PDA-FDA Supply Chain Conference
U.S. FDA Head Says Chinese Heparin Contaminated On Purpose
China To Set Up National Surveillance Network For Controlled Substances
China To Set Up National Surveillance Network For Controlled Substances
Advertisement
UsernamePublicRestriction

Register

SC068226

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel